We are monitoring the impact of COVID-19 on Human Microbiome Market Get in touch with us for detailed analysis Know More
Pulished Date October, 2021
ID: 12290
Share on
Share on

Global Human Microbiome Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report - Segmented By Product, Application, Disease Type & Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa) – Industry Forecast (2021 to 2026)

Pulished: October, 2021
ID: 12290
Pages: 190

Global Human Microbiome Market Size (2021 to 2026)

During the forecast period, the global human microbiome market is expected to register a CAGR of 22.42% and be worth USD 2,497.69 million by 2026 from USD 908.40 million in 2021.

The term "human microbiome" refers to collecting microorganisms that live on or in human tissues and biofluids. The human microbiota is a collection of billions of bacteria that live on the surface of human tissues. Microbes, such as bacteria, fungi, and viruses, are disease-causing agents that accumulate over time. Their genetic activities and metabolic processes are transformed by their habitat in the gut, resulting in an abnormal immune response against substances and tissues usually are present in the human body. Several microbiome projects have been started around the world to understand better the roles that these symbians perform. The gut microbiota has long been linked to a person's overall health and immunity. Variation in the number of microorganisms, such as actinobacteria, firmicute, and Bacteroidetes, has been linked to the development of lung, pulmonary, diabetic, arthritic, gastrointestinal, and other neurological illnesses, according to research.

Impact of COVID-19 on the global human microbiome market:

The COVID-19 pandemic is vital for North American companies and research groups working together with the government to create treatments and diagnostics in the face of future health emergencies. Several universities and significant players are working to develop coronavirus interventions. In the areas of COVID-19, Inflammatory Bowel Disease (IBD), C. difficile infections, Crohn's disease, and diabetes, microbiome therapies have a wide range of uses. Research institutes' rising research activities to discover additional therapeutic uses of the human microbiome are projected to drive the market forward. The microbiome of the lungs is essential for the formation of immune responses to viral infection, and it may influence the outcome of COVID-19. As a result, increased research investigations in the microbiome field are significant drivers of market expansion.

MARKET DRIVERS:

One of the primary factors driving the expansion of the global human microbiome market is the increased use for drug development.

The market is further expected to grow due to the development of human microbiome-based tests for early illness detection and diagnosis and a surge in consumer interest in human microbiome therapeutics development. The rise further influences the market's funding initiatives and government programs to promote drug research and pharmaceutical corporations' increased attempts to discover novel drugs. Furthermore, the worldwide Human Microbiome market is primarily driven by the rising demand for lightweight automobiles due to stringent emission rules. As a result, increased use of lightweight materials for improved safety and fuel efficiency is expected to benefit the market growth during the forecast period.

The global human microbiome market benefits from increasing the elderly population, advancing biotechnology and biopharmaceutical industry investment, and growing research and development activities. Furthermore, the increase in public-private alliances provides market participants with a beneficial opportunity. As a result, there are a variety of high-growth options for important stakeholders to purchase out companies to investigate microbiomes in the hopes of uncovering novel medications and therapeutic targets for a variety of diseases, including obesity, liver illnesses, diabetes, and metabolic disorders.

RESTRAINING FACTORS:

Factors such as government rules, a lack of experience, and insufficient research are predicted to restrict the market expansion. Proving the causal relationship between dysbiosis and diseases is difficult for the global human microbiome market. Clinical trials employing the procedure were set to be stopped by the FDA. With fecal microbiota for transplantation, the FDA warns healthcare practitioners and patients about the risk of severe or life-threatening infections (FMT). As a result, the human microbiome market's expansion may be challenged by the lack of knowledge and insufficient specific research.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Disease, Product, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

 

This research report on the global human microbiome market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2026.

Human Microbiome Market – By Disease:

  • Obesity
  • Diabetes
  • Autoimmune Disorders
  • Cancer
  • Mental Disorders
  • Infectious disease

The infectious disease segment is predicted to grow at the fastest rate during the forecast period based on the disease type. The need for particular bacterial-targeted therapy for contagious diseases has been highlighted as awareness of the adverse effects of antibiotic use on the natural flora has grown. The increasing number of clinical studies for the development of target-specific microbiome-based therapeutics and the rising prevalence of illnesses due to microbial dysbiosis as a result of antibiotic therapy are the primary reasons driving the expansion of this market.

Human Microbiome Market – By Product:

  • Probiotic
  • Foods
  • Medical Foods
  • Diagnostic Device
  • Drugs
  • Supplements

In 2020, the probiotics segment accounted for the most significant share of the global human microbiome market based on the product. Probiotics are beneficial bacteria that help keep your body healthy and functioning correctly. This beneficial bacterium aids you in various ways, including fighting off harmful bacteria when there is an excess of it and making you feel better.

Human Microbiome Market – By Application:

  • Therapeutics
  • Diagnostics

Over the forecast period, therapeutic applications are expected to hold the largest share in the global human microbiome market based on the application. Rising research activities by research institutes to discover additional therapeutic uses of the human microbiome are projected to drive the market forward.

Human Microbiome Market – By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

North America dominates the global human microbiome market because of the increased prevalence of lifestyle-related diseases and autoimmune disorders in these countries. The highly profitable expansion can also be ascribed to the presence of a robust therapeutic pipeline. The government of Canada may invest in seven research teams from around the country to better understand the microbiome's role in pediatric asthma, cervical cancer, diabetes, inflammatory bowel disease in children, and maternal malnutrition. As a result of these research programs and increased government financing, North America has emerged as one of the most important marketplaces for the human microbiome.

Due to improved biotechnological and microbiological research infrastructure, Europe is expected to play a significant role in the global human microbiome market. In addition, increased rates of lifestyle diseases and autoimmune disorders have propelled the Human Microbiome Market's expansion in these regions.

KEY MARKET PARTICIPANTS:

A few of the prominent companies operating in the global human microbiome market profiled in this report are Microbiotica, Rebiotix, Inc., Locus Biosciences, Second Genome Inc., Osel Inc., Second Genome, Kallyope, Finch Therapeutics, Concentric, Synthetic Biologics, Inc., DuPont, BiomX Ltd, MaaT Pharma, Eligo Bioscience, SNIPR Biome, Ritter Pharmaceuticals, DayTwo, Yeda Research and Development Co. Ltd., MyBiome, AOBiome, Enterome, Yakult Honsha Co., Ltd., MicroBiome Therapeutics LLC, and Metabiomics Corporate.

RECENT MARKET DEVELOPMENTS:

  • 4D Pharma combined with Longevity Acquisition Corporation in 2020 to become a NASDAQ-listed company. Longevity will, in turn, support and speed up the development of 4D Pharma's Live Biotherapeutic. The FDA defines Living Biotherapeutics as biological products that contain a live organism, such as a bacterium, and are used to prevent, treat, or cure disease.
  • Gilead Sciences, Inc. and Second Genome, a leader in microbiome science, announced a four-year strategic partnership to find biomarkers linked with clinical response in up to five of Gilead's pipeline drugs in inflammation, fibrosis, and other diseases on April 6, 2020.
  • BiomX and Boehringer Ingelheim teamed in 2020 to use the microbiome-based biomarker discovery platform to find biomarkers linked with patient characteristics in IBD potentially.
  1. Introduction                                 
    1. Market Definition                    
    2. Scope of the report                 
    3. Study Assumptions                 
    4. Base Currency, Base Year and Forecast Periods                           
  2. Research Methodology                                           
    1. Analysis Design                         
    2. Research Phases                      
      1. Secondary Research           
      2. Primary Research 
      3. Data Modelling     
      4. Expert Validation  
    3. Study Timeline                          
  3. Report Overview                                        
    1. Executive Summary                
    2. Key Inferences                       
  4. Market Dynamics                                       
    1. Impact Analysis                        
      1. Drivers      
      2. Restraints 
      3. Opportunities        
    2. Regulatory Environment                       
    3. Technology Timeline & Recent Trends                            
  5. Competitor Benchmarking Analysis                                    
    1. Key Player Benchmarking                     
      1. Market share analysis         
      2. Products/Service 
      3. Regional Presence
    2. Mergers & Acquisition Landscape                      
    3. Joint Ventures & Collaborations                        
  6. Market Segmentation                                              
    1. Global Human Microbiome Market, By Disease
      1. Obesity
      2. Diabetes
      3. Autoimmune Disorders
      4. Cancer
      5. Mental Disorders
      6. Infectious disease
      7. Market Size Estimations & Forecasts (2021-2026)   
      8. Y-o-Y Growth Rate Analysis              
      9. Market Attractiveness Index           
    2. Global Human Microbiome Market, By Product
      1. Probiotic
      2. Foods
      3. Medical Foods
      4. Diagnostic Device
      5. Drugs
      6. Supplements
      7. Market Size Estimations & Forecasts (2021-2026)   
      8. Y-o-Y Growth Rate Analysis              
      9. Market Attractiveness Index         
    3. Global Human Microbiome Market, By Application
      1. Therapeutics
      2. Diagnostics
      3. Market Size Estimations & Forecasts (2021-2026)   
      4. Y-o-Y Growth Rate Analysis              
      5. Market Attractiveness Index         
  7. Geographical Landscape                                         
    1. Global Human Microbiome Market, By Region                 
    2. North America - Market Analysis (2021 - 2026)                            
      1. By Country              
        1. USA
        2. Canada
      2. By Type    
      3. By Target 
    3. Europe                         
      1. By Country              
        1. UK
        2. France
        3. Germany
        4. Spain
        5. Italy
        6. Rest of Europe
      2. By Type    
      3. By Target 
    4. Asia Pacific                  
      1. By Country              
        1. China
        2. India
        3. Japan
        4. South Korea
        5. South East Asia
        6. Australia & NZ
        7. Rest of Asia-Pacific
      2. By Type    
      3. By Target 
    5. Latin America                            
      1. By Country              
        1. Brazil
        2. Argentina
        3. Mexico
        4. Rest of Latin America
      2. By Type    
      3. By Target 
    6. Middle East and Africa                           
      1. By Country              
        1. Middle East
        2. Africa
      2. By Type    
      3. By Target 
  8. Key Player Analysis                                    
    1. Cooper vision
      1. Business Description           
      2. Products/Service 
      3. Financials 
      4. SWOT Analysis      
      5. Recent Developments       
      6. Analyst Overview 
    2. Microbiotica
    3. Rebiotix, Inc
    4. Locus Biosciences
    5. Second Genome Inc.
    6. Osel Inc.
    7. Second Genome
    8. Kallyope
    9. Finch Therapeutics
    10. Concentric
    11. Synthetic Biologics, Inc.
    12. DuPont, BiomX Ltd
    13. MaaT Pharma
    14. Eligo Bioscience
    15. SNIPR Biome
    16. Ritter Pharmaceuticals
    17. DayTwo
    18. Yeda Research and Development Co. Ltd
    19. MyBiome
    20. AOBiome
    21. Enterome
    22. Yakult Honsha Co., Ltd
    23. MicroBiome Therapeutics LLC
    24. Metabiomics Corporate
  9. Market Outlook & Investment Opportunities
    1. Appendix
      1. List of Tables
      2. List of Figures
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of disease, product and application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Human Microbiome Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  3. Global Obesity Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global Diabetes Market, By Region, From 2021 to 2026 (USD Billion)
  5. Global Autoimmune Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  6. Global Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  7. Global Mental Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  8. Global Infectious disease Market, By Region, From 2021 to 2026 (USD Billion)
  9. Global Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  10. Global  Therapeutics Market, By Region, From 2021 to 2026 (USD Billion)
  11. Global Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  12. Global Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  13. Global Probiotic Market, By Region, From 2021 to 2026 (USD Billion)
  14. Global  Foods Market, By Region, From 2021 to 2026 (USD Billion)
  15. Global Medical Foods Market, By Region, From 2021 to 2026 (USD Billion)
  16. Global Diagnostic Device Market, By Region, From 2021 to 2026 (USD Billion)
  17. Global Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  18. Global Supplements Market, By Region, From 2021 to 2026 (USD Billion)
  19. North America Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  20. North America Obesity Market, By Region, From 2021 to 2026 (USD Billion)
  21. North America Diabetes Market, By Region, From 2021 to 2026 (USD Billion)
  22. North America Autoimmune Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  23. North America Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  24. North America Mental Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  25. North America Infectious disease Market, By Region, From 2021 to 2026 (USD Billion)
  26. North America Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  27. North America  Therapeutics Market, By Region, From 2021 to 2026 (USD Billion)
  28. North America Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  29. North America Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  30. North America Probiotic Market, By Region, From 2021 to 2026 (USD Billion)
  31. North America  Foods Market, By Region, From 2021 to 2026 (USD Billion)
  32. North America Medical Foods Market, By Region, From 2021 to 2026 (USD Billion)
  33. North America Diagnostic Device Market, By Region, From 2021 to 2026 (USD Billion)
  34. North America Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  35. North America Supplements Market, By Region, From 2021 to 2026 (USD Billion)
  36. United States Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  37. United States Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  38. United States Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  39. Canada Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  40. Canada Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  41. Canada Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  42. Europe Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  43. Europe Obesity Market, By Region, From 2021 to 2026 (USD Billion)
  44. Europe Diabetes Market, By Region, From 2021 to 2026 (USD Billion)
  45. Europe Autoimmune Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  46. Europe Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  47. Europe Mental Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  48. Europe Infectious disease Market, By Region, From 2021 to 2026 (USD Billion)
  49. Europe Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  50. Europe  Therapeutics Market, By Region, From 2021 to 2026 (USD Billion)
  51. Europe Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  52. Europe Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  53. Europe Probiotic Market, By Region, From 2021 to 2026 (USD Billion)
  54. Europe  Foods Market, By Region, From 2021 to 2026 (USD Billion)
  55. Europe Medical Foods Market, By Region, From 2021 to 2026 (USD Billion)
  56. Europe Diagnostic Device Market, By Region, From 2021 to 2026 (USD Billion)
  57. Europe Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  58. Europe Supplements Market, By Region, From 2021 to 2026 (USD Billion)
  59. U.K. Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  60. U.K. Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  61. U.K. Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  62. Germany Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  63. Germany Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  64. Germany Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  65. France Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  66. France Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  67. France Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  68. Italy Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  69. Italy Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  70. Italy Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  71. Spain Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  72. Spain Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  73. Spain Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  74. Asia Pacific Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  75. Asia Pacific Obesity Market, By Region, From 2021 to 2026 (USD Billion)
  76. Asia Pacific Diabetes Market, By Region, From 2021 to 2026 (USD Billion)
  77. Asia Pacific Autoimmune Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  78. Asia Pacific Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  79. Asia Pacific Mental Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  80. Asia Pacific Infectious disease Market, By Region, From 2021 to 2026 (USD Billion)
  81. Asia Pacific Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  82. Asia Pacific  Therapeutics Market, By Region, From 2021 to 2026 (USD Billion)
  83. Asia Pacific Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  84. Asia Pacific Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  85. Asia Pacific Probiotic Market, By Region, From 2021 to 2026 (USD Billion)
  86. Asia Pacific  Foods Market, By Region, From 2021 to 2026 (USD Billion)
  87. Asia Pacific Medical Foods Market, By Region, From 2021 to 2026 (USD Billion)
  88. Asia Pacific Diagnostic Device Market, By Region, From 2021 to 2026 (USD Billion)
  89. Asia Pacific Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  90. Asia Pacific Supplements Market, By Region, From 2021 to 2026 (USD Billion)
  91. Japan Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  92. Japan Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  93. Japan Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  94. China Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  95. China Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  96. China Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  97. India Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  98. India Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  99. India Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  100. Australia Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  101. Australia Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  102. Australia Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  103. South Korea Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  104. South Korea Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  105. South Korea Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  106. Latin America Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  107. Latin America Obesity Market, By Region, From 2021 to 2026 (USD Billion)
  108. Latin America Diabetes Market, By Region, From 2021 to 2026 (USD Billion)
  109. Latin America Autoimmune Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  110. Latin America Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  111. Latin America Mental Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  112. Latin America Infectious disease Market, By Region, From 2021 to 2026 (USD Billion)
  113. Latin America Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  114. Latin America  Therapeutics Market, By Region, From 2021 to 2026 (USD Billion)
  115. Latin America Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  116. Latin America Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  117. Latin America Probiotic Market, By Region, From 2021 to 2026 (USD Billion)
  118. Latin America  Foods Market, By Region, From 2021 to 2026 (USD Billion)
  119. Latin America Medical Foods Market, By Region, From 2021 to 2026 (USD Billion)
  120. Latin America Diagnostic Device Market, By Region, From 2021 to 2026 (USD Billion)
  121. Latin America Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  122. Latin America Supplements Market, By Region, From 2021 to 2026 (USD Billion)
  123. Brazil Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  124. Brazil Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  125. Brazil Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  126. Argentina Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  127. Argentina Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  128. Argentina Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  129. Mexico Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  130. Mexico Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  131. Mexico Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  132. Rest of Latin America Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  133. Rest of Latin America Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  134. Rest of Latin America Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  135. Middle East and Africa Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  136. Middle East and Africa Obesity Market, By Region, From 2021 to 2026 (USD Billion)
  137. Middle East and Africa Diabetes Market, By Region, From 2021 to 2026 (USD Billion)
  138. Middle East and Africa Autoimmune Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  139. Middle East and Africa Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  140. Middle East and Africa Mental Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  141. Middle East and Africa Infectious disease Market, By Region, From 2021 to 2026 (USD Billion)
  142. Middle East and Africa Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  143. Middle East and Africa  Therapeutics Market, By Region, From 2021 to 2026 (USD Billion)
  144. Middle East and Africa Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  145. Middle East and Africa Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  146. Middle East and Africa Probiotic Market, By Region, From 2021 to 2026 (USD Billion)
  147. Middle East and Africa  Foods Market, By Region, From 2021 to 2026 (USD Billion)
  148. Middle East and Africa Medical Foods Market, By Region, From 2021 to 2026 (USD Billion)
  149. Middle East and Africa Diagnostic Device Market, By Region, From 2021 to 2026 (USD Billion)
  150. Middle East and Africa Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  151. Middle East and Africa Supplements Market, By Region, From 2021 to 2026 (USD Billion)
  152. Middle East Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  153. Middle East Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  154. Middle East Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  155. Africa Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  156. Africa Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  157. Africa Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample